This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Agency for Science, Technology and Research. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: **Innovations of Guillaume Robert Carissimo in Infectious Disease Evaluation**
Introduction
Guillaume Robert Carissimo, an accomplished inventor based in Singapore, has made significant contributions to the field of medical science. His innovative approach focuses on evaluating the progression of infectious and inflammatory diseases, a crucial aspect in improving patient outcomes.
Latest Patents
Guillaume holds a patent for a unique method of assessing the risk of severe outcomes in infectious and inflammatory diseases. This method involves measuring specific immune cells, including VD2 T cells, CD8 T cells, and immature neutrophils from patient samples. The findings indicate that a patient may have an enhanced risk of severe health outcomes if certain conditions regarding the ratios of these immune cells are met. Additionally, his patent also covers methods for treating patients afflicted with severe manifestations of these diseases and a kit designed for application in these methods.
Career Highlights
Guillaume Robert Carissimo is associated with the Agency for Science, Technology and Research (A*STAR), which is noted for its commitment to advancing important scientific research and innovation. His work in evaluating disease progression contributes significantly to the field of immunology and provides valuable insights for clinical applications.
Collaborations
Throughout his career, Carissimo has collaborated with esteemed colleagues, including Immanuel Kwok Weng Han and Weili Xu. These partnerships highlight the collaborative nature of innovative research, allowing for the cross-pollination of ideas and expertise in advancing medical science.
Conclusion
Guillaume Robert Carissimo’s contributions through his patent and research have broad implications in the landscape of infectious diseases. By focusing on immune cell evaluation, he stands at the forefront of innovation, ensuring better assessment and treatment strategies are available for patients. His work exemplifies the impact of dedicated inventors in the medical community, shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile